Chinese multidisciplinary expert consensus: Guidelines on percutaneous transthoracic needle biopsy

Abstract

Biopsy has been used to diagnose thoracic diseases for more than a century. Percutaneous needle biopsy plays a crucial role in the diagnosis, staging, and treatment planning for tumors in the lungs, thoracic wall, hilum, and mediastinum. With the continuous improvement in imaging techniques, the range of clinical applications for percutaneous needle biopsy is also expanding. It has become important to improve Chinese professionals’ and technicians’ understanding of percutaneous transthoracic needle biopsy (PTNB) in order to standardize operating procedures and to strengthen perioperative management. However, there is currently no Chinese expert consensus that provides systematic standardization and guidance for PTNB in clinical practice. The Committee of Chinese Society of Interventional Oncology (CSIO) of the Chinese Anti‐Cancer Association (CACA) initiated a Chinese multidisciplinary expert consensus on PTNB. The consensus includes image‐guided methods, indications, contraindications, multidisciplinary team recommendations, biopsy procedures, daytime/outpatient biopsy, complications, pathological examination, and management of negative results.

Hemorrhagic shock necessitating resuscitation and damage control surgery after needle biopsy: A report of two cases

“…Percutaneous needle biopsy is less invasive than surgical biopsy, and some of its complications, such as bleeding, infection, peritonitis, pleural injury, and pain, are more likely to be overlooked [ [6] , [7] , [8] ]. The most dangerous complication in liver biopsy is bleeding.…”

“…On the other hand, common and serious complications of thoracic needle biopsy include not only bleeding but also pneumothorax. Pneumothorax was the most common complication according to two reports, occurring in 35% of patients who underwent thoracic needle biopsy [ 8 , 9 ]. The mortality rate was between 0.02% and 0.15% [ 8 , 9 ].…”

“…Pneumothorax was the most common complication according to two reports, occurring in 35% of patients who underwent thoracic needle biopsy [ 8 , 9 ]. The mortality rate was between 0.02% and 0.15% [ 8 , 9 ]. Biopsy is performed in order to examine in detail malignant diseases that have caused coagulopathy [ 5 ].…”

Correlation between percutaneous transthoracic needle biopsy and recurrence in stage I lung cancer: a systematic review and meta-analysis

“…But the operation's safety of metastasis along the needle tract has not yet been determined. Some studies have shown that this operation will have the risk of breast wall implant metastasis [1,2], pleural metastasis [3] [4]and so on, while other studies showed that this operation is safe in the diagnosis [5,6], and tumor metastasis along the needle track is relatively rare [7]. The purpose of this meta-analysis is to evaluate the risk of recurrence in patients with lung cancer caused by PTNB and to provide evidence-based medicine in clinical diagnosis.…”

Correlation between percutaneous transthoracic needle biopsy and recurrence in stage I lung cancer: a systematic review and meta-analysis

“…But the operation's safety of metastasis along the needle tract has not yet been determined. Some studies have shown that this operation will have the risk of breast wall implant metastasis [1], pleural metastasis [2,3] and so on, while other studies showed that this operation is safe in the diagnosis [4,5], and tumor metastasis along the needle track is relatively rare [6]. The purpose of this metaanalysis is to evaluate the risk of recurrence in patients with lung cancer caused by PTNB and to provide evidence-based medicine in clinical diagnosis.…”